Syndrome  >>  lisdexamfetamine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lisdexamfetamine / Generic mfg.
NCT01714310: Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation

Completed
2
34
US
lisdexamfetamine, Vyvanse, Placebo, fluoxetine, Prozac
University of California, Los Angeles, National Institute of Mental Health (NIMH), Shire
Severe Mood Dysregulation
06/16
06/16

Download Options